Proactive Adalimumab Monitoring in Inflammatory Bowel Disease: Current Data and Future Perspectives

Lignende værker

• Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease
  af: Papamichael, Konstantinos, et al.
  Udgivet: (2019)
• Maintenance adalimumab concentrations are associated with biochemical, endoscopic and histologic remission in inflammatory bowel disease
  af: Juncadella, Anna, et al.
  Udgivet: (2018)
• Proactive Infliximab Monitoring Following Reactive Testing is Associated With Better Clinical Outcomes Than Reactive Testing Alone in Patients With Inflammatory Bowel Disease
  af: Papamichael, Konstantinos, et al.
  Udgivet: (2018)
• Comparison between assays used for therapeutic drug monitoring of infliximab and adalimumab in inflammatory bowel disease
  af: Papamichael, Konstantinos, et al.
  Udgivet: (2020)
• Improved Long-Term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab
  af: Papamichael, Konstantinos, et al.
  Udgivet: (2017)